December 6, 1999

registration of the Company.

February 4, 2000

the company obtains the permit to operate within the TSEZ (Tarnobrzeg Special Economic Zone)

December 2000

in a small barrack, converted into its first registered office - after having received a concession from the Main Pharmaceutical Inspector and subsequently an indefinite permit from the Health Minister - the Company begins manual packing of Gałazolina

November 10, 2001

a cornerstone is laid for the Dry Dosage Forms Factory.

October 16, 2003

a new object is opened – at that time still without a Tablet press, but including a Packing Facility equipped with the most up-to-date packing lines, and a modern High Storage Warehouse.

April 16, 2004

Polish Pharmaceutical Holding is founded by the Minister of Treasury, consisting of, among others: Polfa Warszawa Corporate Group, owner of Sanfram;

December 2005

the company manufactures its first series of tablets.

April 2006

The Minister of Economy issues a decision, changing the Company’s permit to operate within the Special Economic Zone, expanding the Company’s activity, mainly in the scope of dietary supplements manufacturing.

June 2007

the company receives the GMP certificate, confirming compliance of manufacturing conditions with the Good Manufacturing Practice.

October 28, 2008

a new challenge – manufacture of tablets for the purpose of clinical studies.

December 2010

renewal of the GMP certificate.

December 2010

due to the planned investments regarding equipment expansion, modernization of packing lines and tablet presses, the company receives a new permit to operate within the zone.